All posts tagged
Amgen Joins €50M German Fundraising for T-Cell Receptor Cancer Immunotherapy
German Pharma Enters the Clinic with Solid Tumor Treatment
German Biotech Starts Trials with a Personalized Cell Therapy for Multiple Cancers
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
German Immuno-Oncology Biotech partners up with Biotech Giant Amgen
What happened this week? 40th birthday of Monoclonal Antibodies, Surgerys change Microbiome, UniQure struggles with FDA …
Leading German Biotechs MorphoSys and Immatics partner to pump up their Immuno-Oncology Therapies
You have 20 minutes? Use it to watch LaBiotech Tour South Germany!
LaBiotech Tour South Germany’s online Premiere on December 18!
European’s First Personalized Vaccines to Treat Brain Cancer
Labiotech UG, All Rights Reserved -
Send this to a friend